Illumina

A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021.Mike Blake | ReutersIllumina on Tuesday unveiled plans to cut costs in a bid to improve the DNA sequencing company's…

Francis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 19, 2023.Stefan Wermuth | Bloomberg | Getty ImagesThe Federal Trade…

Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016.David A. Grogan | CNBCCarl Icahn blasted Illumina for nearly doubling its CEO's pay last year despite a dramatic drop in the biotech company's market value since closing…

Rafael Henrique | Lightrocket | Getty ImagesIllumina on Thursday urged shareholders to reject Carl Icahn's three board nominees at this year's annual meeting, saying they would "threaten the progress" of the biotech company's core business.…

Carl Icahn on Friday alleged that Illumina's directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest…

Carl IcahnAdam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees "do not add value." The…

Check out the companies making headlines before the bell:Honest Company (HNST) – Honest Company's stock rose 1.6% in the premarket in spite of a wider-than-expected quarterly loss. The natural consumer products maker now sees a wider…

A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genomics company BGI Group after finding that Illumina's DNA-sequencing systems infringed two patents.The jury also said Illumina…

Offices of Illumina, in San Diego, California.Mike Blake | ReutersCheck out the companies making headlines in midday trading.Illumina – Illumina shares surged 12.7% a day after the biotechnology company issued a 2022 revenue outlook that…

NEW YORK: Stocks that traded heavily or had substantial price changes Tuesday:Illumina Inc., up $61.52 to $423.80.The genetic testing tools company gave investors an encouraging revenue forecast and update on partnerships.Shake Shack Inc.,…